Nutriband Inc. Warrant financials
$1.66+26.72%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY26 Jan 31 | FY25 Jan 31 | FY24 Jan 31 | FY23 Jan 31 | FY22 Jan 31 |
|---|---|---|---|---|---|
| Revenue | $2.0M | $2.1M | $2.1M | $2.1M | $1.4M |
| Gross profit | $566.3K | $743.3K | $862.1K | $750.4K | $504.3K |
| Gross margin | 27.8% | 34.7% | 41.3% | 36.1% | 35.5% |
| Operating income | -$8.3M | -$10.3M | -$4.9M | -$4.5M | -$6.1M |
| Net income | -$30.0M | -$10.5M | -$5.5M | -$4.5M | -$6.4M |
| Net margin | −1475.2% | −489.9% | −263.0% | −215.6% | −448.1% |
| Diluted EPS | $-2.58 | $-0.99 | $-0.55 | $-0.42 | $-0.64 |
| EBITDA | -$8.1M | -$6.4M | -$4.6M | -$3.8M | -$3.6M |
| Operating cash flow | -$5.1M | -$4.6M | -$3.5M | -$3.0M | -$2.8M |
| Free cash flow | -$5.1M | -$4.7M | -$3.6M | -$3.1M | -$2.9M |
| Diluted shares | 11.6M | 10.6M | 9.9M | 10.6M | 9.9M |
Balance sheet
| Period end | Jan 31 | Jan 31 | Jan 31 | Jan 31 | Jan 31 |
|---|---|---|---|---|---|
| Cash & equivalents | $4.6M | $4.3M | $492.9K | $2.0M | $4.9M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Total debt | $164.7K | $186.3K | $207.0K | $120.2K | $115.2K |
| Total assets | $7.5M | $7.5M | $7.5M | $9.5M | $12.7M |
| Total liabilities | $868.4K | $1.0M | $1.1M | $883.4K | $880.4K |
| Shareholders' equity | $6.7M | $6.4M | $6.4M | $8.6M | $11.9M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology